![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Active Filter(s):
Details:
This acquisition brings together globally recognized vitamin K2 brands vitaMK7® and MenaQ7® and allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.
Lead Product(s): Vitamin K2
Therapeutic Area: Musculoskeletal Product Name: MenaQ7
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Gnosis by Lesaffre
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition May 25, 2021